Consideration of and expectations for the Pharmaceuticals, Medical Devices and Other Therapeutic Products Act in Japan()

The Japanese regulatory framework for pharmaceuticals and medical devices has recently been reexamined and the revised Pharmaceutical Affairs Law, which has been renamed the Pharmaceuticals, Medical Devices and Other Therapeutic Products Act, was developed in 2013 and implemented in November 2014. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Okada, Kiyoshi, Koike, Kazuhisa, Sawa, Yoshiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581820/
https://www.ncbi.nlm.nih.gov/pubmed/31245444
http://dx.doi.org/10.1016/j.reth.2015.04.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581820/
https://www.ncbi.nlm.nih.gov/pubmed/31245444
http://dx.doi.org/10.1016/j.reth.2015.04.001

Ejemplares similares